Association of inflammatory factors with occurrence and recurrence of atrial fibrillation: A meta-analysis
Tóm tắt
Từ khóa
Tài liệu tham khảo
Kannel, 2008, Status of the epidemiology of atrial fibrillation, Med Clin North Am, 92, 17, 10.1016/j.mcna.2007.09.002
Climent, 2009, Influence of electrical cardioversion on inflammation and indexes of structural remodeling, in persistent atrial fibrillation, Int J Cardiol, 132, 227, 10.1016/j.ijcard.2007.11.044
O'Neill, 2007, Catheter ablation for atrial fibrillation, Circulation, 116, 1515, 10.1161/CIRCULATIONAHA.106.655738
Elahi, 2003, Incidence and clinical consequences of atrial fibrillation within 1year of first-time isolated coronary bypass surgery, Circulation, 108, II207
Chugh, 2001, Epidemiology and natural history of atrial fibrillation: clinical implications, J Am Coll Cardiol, 37, 371, 10.1016/S0735-1097(00)01107-4
Chung, 2001, C-reactive protein elevation in patients with atrial arrhythmias: inflammatory mechanisms and persistence of atrial fibrillation, Circulation, 104, 2886, 10.1161/hc4901.101760
Dernellis, 2001, C-reactive protein and paroxysmal atrial fibrillation: evidence of the implication of an inflammatory process in paroxysmal atrial fibrillation, Acta Cardiol, 56, 375, 10.2143/AC.56.6.2005701
Ellinor, 2006, C-reactive protein in lone atrial fibrillation, Am J Cardiol, 97, 1346, 10.1016/j.amjcard.2005.11.052
Aviles, 2003, Inflammation as a risk factor for atrial fibrillation, Circulation, 108, 3006, 10.1161/01.CIR.0000103131.70301.4F
Dernellis, 2006, Effects of C-reactive protein and the third and fourth components of complement (C3 and C4) on incidence of atrial fibrillation, Am J Cardiol, 97, 245, 10.1016/j.amjcard.2005.08.027
Casaclang-Verzosa, 2010, C-reactive protein, left atrial volume, and atrial fibrillation: a prospective study in high-risk elderly, Echocardiography, 27, 394, 10.1111/j.1540-8175.2009.01039.x
Schnabel, 2009, Relation of multiple inflammatory biomarkers to incident atrial fibrillation, Am J Cardiol, 104, 92, 10.1016/j.amjcard.2009.02.053
Targonski, 2008, Relationship between inflammatory markers and clinical patterns of atrial fibrillation in patients with congestive heart failure, Kardiol Pol, 66, 729
Liuba, 2008, Source of inflammatory markers in patients with atrial fibrillation, Europace, 10, 848, 10.1093/europace/eun111
Pellegrino, 2013, Inflammatory activation in an unselected population of subjects with atrial fibrillation: links with structural heart disease, atrial remodeling and recent onset, Intern Emerg Med, 8, 123, 10.1007/s11739-011-0557-z
Dai, 2009, C-reactive protein and atrial fibrillation in idiopathic dilated cardiomyopathy, Clin Cardiol, 32, E45, 10.1002/clc.20430
De Gennaro, 2012, Inflammatory activation and carbohydrate antigen-125 levels in subjects with atrial fibrillation, Eur J Clin Invest, 42, 371, 10.1111/j.1365-2362.2011.02592.x
Kaireviciute, 2010, Characterisation and validity of inflammatory biomarkers in the prediction of post-operative atrial fibrillation in coronary artery disease patients, Thromb Haemost, 104, 122, 10.1160/TH09-12-0837
Gibson, 2010, Usefulness of neutrophil/lymphocyte ratio as predictor of new-onset atrial fibrillation after coronary artery bypass grafting, Am J Cardiol, 105, 186, 10.1016/j.amjcard.2009.09.007
Garcia, 2012, Impaired cardiac autophagy in patients developing postoperative atrial fibrillation, J Thorac Cardiovasc Surg, 143, 451, 10.1016/j.jtcvs.2011.07.056
Osmancik, 2010, Changes in cytokine concentrations following successful ablation of atrial fibrillation, Eur Cytokine Netw, 21, 278
Leftheriotis, 2009, The predictive value of inflammatory and oxidative markers following the successful cardioversion of persistent lone atrial fibrillation, Int J Cardiol, 135, 361, 10.1016/j.ijcard.2008.04.012
Watanabe, 2006, High-sensitivity C-reactive protein is predictive of successful cardioversion for atrial fibrillation and maintenance of sinus rhythm after conversion, Int J Cardiol, 108, 346, 10.1016/j.ijcard.2005.05.021
Tveit, 2007, Effect of candesartan and various inflammatory markers on maintenance of sinus rhythm after electrical cardioversion for atrial fibrillation, Am J Cardiol, 99, 1544, 10.1016/j.amjcard.2007.01.030
Henningsen, 2009, Prognostic impact of hs-CRP and IL-6 in patients undergoing radiofrequency catheter ablation for atrial fibrillation, Scand Cardiovasc J, 43, 285, 10.1080/14017430802653676
Liu, 2011, High-sensitivity C-reactive protein as a predictor of atrial fibrillation recurrence after primary circumferential pulmonary vein isolation, Pacing Clin Electrophysiol, 34, 398, 10.1111/j.1540-8159.2010.02978.x
Liu, 2007, Association between C-reactive protein and recurrence of atrial fibrillation after successful electrical cardioversion: a meta-analysis, J Am Coll Cardiol, 49, 1642, 10.1016/j.jacc.2006.12.042
Celebi, 2011, The effect of sinus rhythm restoration on high-sensitivity C-reactive protein levels and their association with long-term atrial fibrillation recurrence after electrical cardioversion, Cardiology, 118, 168, 10.1159/000327998
Falcone, 2010, Apelin plasma levels predict arrhythmia recurrence in patients with persistent atrial fibrillation, Int J Immunopathol Pharmacol, 23, 917, 10.1177/039463201002300328
Vizzardi, 2009, High sensitivity C-reactive protein: a predictor for recurrence of atrial fibrillation after successful cardioversion, Intern Emerg Med, 4, 309, 10.1007/s11739-009-0235-6
Lombardi, 2008, C-reactive protein but not atrial dysfunction predicts recurrences of atrial fibrillation after cardioversion in patients with preserved left ventricular function, J Cardiovasc Med (Hagerstown), 9, 581, 10.2459/JCM.0b013e3282f3524d
Kallergis, 2008, The role of the post-cardioversion time course of hs-CRP levels in clarifying the relationship between inflammation and persistence of atrial fibrillation, Heart, 94, 200, 10.1136/hrt.2006.108688
Gomez Martinez, 2007, Inflammatory state in patients with atrial fibrillation before and after electrical cardioversion, Med Intensiva, 31, 126
Kim, 2009, Clinical and serological predictors for the recurrence of atrial fibrillation after electrical cardioversion, Europace, 11, 1632, 10.1093/europace/eup321
Naji, 2011, Lipoprotein(a) and inflammation in patients with atrial fibrillation after electrical cardioversion, J Negat Results Biomed, 10, 15, 10.1186/1477-5751-10-15
Ferro, 2012, Serum levels of vitamin E are associated with early recurrence of atrial fibrillation after electric cardioversion, Circ Arrhythm Electrophysiol, 5, 327, 10.1161/CIRCEP.111.968248
Henningsen, 2009, Prognostic impact of hs-CRP and IL-6 in patients with persistent atrial fibrillation treated with electrical cardioversion, Scand J Clin Lab Invest, 69, 425, 10.1080/00365510802676848
Colkesen, 2008, Mean platelet volume is elevated during paroxysmal atrial fibrillation: a marker of increased platelet activation?, Blood Coagul Fibrinolysis, 19, 411, 10.1097/MBC.0b013e3283049697
Ichiki, 2009, The role of infection in the development of non-valvular atrial fibrillation: up-regulation of Toll-like receptor 2 expression levels on monocytes, J Cardiol, 53, 127, 10.1016/j.jjcc.2008.09.008
Ki, 2010, Frequency of vacuolating cytotoxin A (VacA)-positive Helicobacter pylori seropositivity and TGF-beta1 decrease in atrial fibrillation, Int J Cardiol, 145, 345, 10.1016/j.ijcard.2009.12.009
Scridon, 2012, Increased intracardiac vascular endothelial growth factor levels in patients with paroxysmal, but not persistent atrial fibrillation, Europace, 14, 948, 10.1093/europace/eur418
Li, 2010, Role of inflammation and oxidative stress in atrial fibrillation, Heart Rhythm, 7, 438, 10.1016/j.hrthm.2009.12.009
Qu, 2009, Activated nuclear factor-kappaB and increased tumor necrosis factor-alpha in atrial tissue of atrial fibrillation, Scand Cardiovasc J, 43, 292, 10.1080/14017430802651803
Roldan, 2003, Interleukin-6, endothelial activation and thrombogenesis in chronic atrial fibrillation, Eur Heart J, 24, 1373, 10.1016/S0195-668X(03)00239-2
Barani, 2006, Cardiac function, inflammatory mediators and mortality in critical limb ischemia, Angiology, 57, 437, 10.1177/0003319706290743
Neuman, 2007, Oxidative stress markers are associated with persistent atrial fibrillation, Clin Chem, 53, 1652, 10.1373/clinchem.2006.083923
Stroup, 2000, Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group, JAMA, 283, 2008, 10.1001/jama.283.15.2008
Little, 2002, Reporting, appraising, and integrating data on genotype prevalence and gene–disease associations, Am J Epidemiol, 156, 300, 10.1093/oxfordjournals.aje.a000179
Wells, 2011
Hozo, 2005, Estimating the mean and variance from the median, range, and the size of a sample, BMC Med Res Methodol, 5, 13, 10.1186/1471-2288-5-13
Begg, 1994, Operating characteristics of a rank correlation test for publication bias, Biometrics, 50, 1088, 10.2307/2533446
Zarauza, 2006, Relationship between C-reactive protein level and early recurrence of atrial fibrillation after electrical cardioversion, Rev Esp Cardiol, 59, 125, 10.1157/13084639
You, 2010, The role of high-sensitivity C-reactive protein, interleukin-6 and cystatin C in ischemic stroke complicating atrial fibrillation, J Huazhong Univ Sci Technolog Med Sci, 30, 648, 10.1007/s11596-010-0558-6
Shin, 2011, Improved endothelial function in patients with atrial fibrillation through maintenance of sinus rhythm by successful catheter ablation, J Cardiovasc Electrophysiol, 22, 376, 10.1111/j.1540-8167.2010.01919.x
Luan, 2010, Interleukin-18 among atrial fibrillation patients in the absence of structural heart disease, Europace, 12, 1713, 10.1093/europace/euq321
Letsas, 2010, Uric acid elevation in atrial fibrillation, Hellenic J Cardiol, 51, 209
Ozaydin, 2010, Factors associated with the development of atrial fibrillation in patients with rheumatic mitral stenosis, Int J Cardiovasc Imaging, 26, 547, 10.1007/s10554-010-9609-0
Marcus, 2010, Intracardiac and extracardiac markers of inflammation during atrial fibrillation, Heart Rhythm, 7, 149, 10.1016/j.hrthm.2009.10.004
Zhang, 2009, Relation of urotensin II levels to lone atrial fibrillation, Am J Cardiol, 104, 1704, 10.1016/j.amjcard.2009.07.053
Tsioufis, 2010, Relationships of CRP and P wave dispersion with atrial fibrillation in hypertensive subjects, Am J Hypertens, 23, 202, 10.1038/ajh.2009.231
Chen, 2009, Association of ATP-binding cassette transporter A1 R219K polymorphism with atrial fibrillation, Nan Fang Yi Ke Da Xue Xue Bao, 29, 494
Toutouzas, 2009, Inflammation in lone atrial fibrillation: new insights by coronary sinus thermography, Int J Cardiol, 134, 345, 10.1016/j.ijcard.2008.02.028
Qian, 2008, Study on levels of angiotensin converting enzyme and C-reactive protein in peripheral blood of mitral valve replacement preoperative patients with atrial fibrillation, Sichuan Da Xue Xue Bao Yi Xue Ban, 39, 122
Marcus, 2008, Interleukin-6 and atrial fibrillation in patients with coronary artery disease: data from the heart and soul study, Am Heart J, 155, 303, 10.1016/j.ahj.2007.09.006
Pirat, 2007, Comparison of C-reactive protein levels in patients who do and do not develop atrial fibrillation during electrophysiologic study, Am J Cardiol, 100, 1552, 10.1016/j.amjcard.2007.06.056
Selcuk, 2007, Relationship between inflammation and atrial fibrillation in patients with isolated rheumatic mitral stenosis, J Heart Valve Dis, 16, 468
Badran, 2007, Cytotoxin-associated gene-A bearing strains of Helicobacter pylori and atrial fibrillation due to ischemic origin: is there a link?, Eur J Cardiovasc Prev Rehabil, 14, 518, 10.1097/HJR.0b013e328011a2a0
Hammwohner, 2007, Platelet expression of CD40/CD40 ligand and its relation to inflammatory markers and adhesion molecules in patients with atrial fibrillation, Exp Biol Med (Maywood), 232, 581
Okamura, 2007, Ratio of LDL- to HDL-associated platelet-activating factor acetylhydrolase may be a marker of inflammation in patients with paroxysmal atrial fibrillation, Circ J, 71, 214, 10.1253/circj.71.214
Gedikli, 2007, Inflammatory markers according to types of atrial fibrillation, Int J Cardiol, 120, 193, 10.1016/j.ijcard.2006.09.015
Hatzinikolaou-Kotsakou, 2006, Relation of C-reactive protein to the first onset and the recurrence rate in lone atrial fibrillation, Am J Cardiol, 97, 659, 10.1016/j.amjcard.2005.09.104
Wang, 2005, Changes of interleukin-1beta and tumor necrosis factor-alpha of right atrial appendages in patients with rheumatic valvular disease complicated with chronic atrial fibrillation, Zhonghua Xin Xue Guan Bing Za Zhi, 33, 522
Watanabe, 2005, C-reactive protein elevation predicts the occurrence of atrial structural remodeling in patients with paroxysmal atrial fibrillation, Heart Vessels, 20, 45, 10.1007/s00380-004-0800-x
Psychari, 2005, Relation of elevated C-reactive protein and interleukin-6 levels to left atrial size and duration of episodes in patients with atrial fibrillation, Am J Cardiol, 95, 764, 10.1016/j.amjcard.2004.11.032
Asselbergs, 2005, C-reactive protein and microalbuminuria are associated with atrial fibrillation, Int J Cardiol, 98, 73, 10.1016/j.ijcard.2003.12.028
Anderson, 2004, Frequency of elevation of C-reactive protein in atrial fibrillation, Am J Cardiol, 94, 1255, 10.1016/j.amjcard.2004.07.108
Conway, 2004, Predictive value of indexes of inflammation and hypercoagulability on success of cardioversion of persistent atrial fibrillation, Am J Cardiol, 94, 508, 10.1016/j.amjcard.2004.04.070
Conway, 2004, Relationship of interleukin-6 and C-reactive protein to the prothrombotic state in chronic atrial fibrillation, J Am Coll Cardiol, 43, 2075, 10.1016/j.jacc.2003.11.062
Li-Saw-Hee, 2000, Effect of degree of blood pressure on the hypercoagulable state in chronic atrial fibrillation, Am J Cardiol, 86, 795, 10.1016/S0002-9149(00)01086-9
Mondillo, 2000, Correlation between left atrial size, prothrombotic state and markers of endothelial dysfunction in patients with lone chronic nonrheumatic atrial fibrillation, Int J Cardiol, 75, 227, 10.1016/S0167-5273(00)00336-3
Feng, 2001, Hemostatic state and atrial fibrillation (the Framingham offspring study), Am J Cardiol, 87, 168, 10.1016/S0002-9149(00)01310-2
Li-Saw-Hee, 2001, Plasma von Willebrand factor, fibrinogen and soluble P-selectin levels in paroxysmal, persistent and permanent atrial fibrillation. Effects of cardioversion and return of left atrial function, Eur Heart J, 22, 1741, 10.1053/euhj.2000.2531
Kamath, 2002, A study of platelet activation in paroxysmal, persistent and permanent atrial fibrillation, Blood Coagul Fibrinolysis, 13, 627, 10.1097/00001721-200210000-00008
Conway, 2003, Atrial fibrillation and the prothrombotic state in the elderly: the Rotterdam study, Stroke, 34, 413, 10.1161/01.STR.0000051728.85133.32
Wang, 2010, Association between transforming growth factor beta1 polymorphisms and atrial fibrillation in essential hypertensive subjects, J Biomed Sci, 17, 23, 10.1186/1423-0127-17-23
Liu, 2011, Uric acid levels and atrial fibrillation in hypertensive patients, Intern Med, 50, 799, 10.2169/internalmedicine.50.4587
Fan, 2012, NT-proBNP, but not ANP and C-reactive protein, is predictive of paroxysmal atrial fibrillation in patients undergoing pulmonary vein isolation, J Interv Card Electrophysiol, 33, 93, 10.1007/s10840-011-9606-9
Liu, 2012, Activation of peripheral blood CD3(+) T-lymphocytes in patients with atrial fibrillation, Int Heart J, 53, 221, 10.1536/ihj.53.221
Lip, 1996, Fibrinogen and fibrin D-dimer levels in paroxysmal atrial fibrillation: evidence for intermediate elevated levels of intravascular thrombogenesis, Am Heart J, 131, 724, 10.1016/S0002-8703(96)90278-1
Hatzinikolaou-Kotsakou, 2003, Atrial fibrillation and hypercoagulability: dependent on clinical factors or/and on genetic alterations?, J Thromb Thrombolysis, 16, 155, 10.1023/B:THRO.0000024053.45693.fc
Cheng, 2012, Correlation between atrial fibrillation, serum amyloid protein A and other inflammatory cytokines, Mol Med Rep, 6, 581, 10.3892/mmr.2012.934
Schnabel, 2010, Relations of biomarkers of distinct pathophysiological pathways and atrial fibrillation incidence in the community, Circulation, 121, 200, 10.1161/CIRCULATIONAHA.109.882241
Antoniades, 2009, Preoperative sCD40L levels predict risk of atrial fibrillation after off-pump coronary artery bypass graft surgery, Circulation, 120, S170, 10.1161/CIRCULATIONAHA.108.843599
Gasparovic, 2010, NT-pro-BNP, but not C-reactive protein, is predictive of atrial fibrillation in patients undergoing coronary artery bypass surgery, Eur J Cardiothorac Surg, 37, 100, 10.1016/j.ejcts.2009.07.003
Choi, 2009, Risk factors of atrial fibrillation following off-pump coronary artery bypass graft surgery: predictive value of C-reactive protein and transfusion requirement, Eur J Cardiothorac Surg, 36, 838, 10.1016/j.ejcts.2009.05.003
Fontes, 2009, Increased preoperative white blood cell count predicts postoperative atrial fibrillation after coronary artery bypass surgery, J Cardiothorac Vasc Anesth, 23, 484, 10.1053/j.jvca.2009.01.030
Sezai, 2009, Study of the factors related to atrial fibrillation after coronary artery bypass grafting: a search for a marker to predict the occurrence of atrial fibrillation before surgical intervention, J Thorac Cardiovasc Surg, 137, 895, 10.1016/j.jtcvs.2008.10.003
Oc, 2008, Heat shock protein70: a new marker for subsequent atrial fibrillation development?, Artif Organs, 32, 846, 10.1111/j.1525-1594.2008.00640.x
Ziabakhsh-Tabari, 2008, Can perioperative C-reactive protein and interleukin-6 levels predict atrial fibrillation after coronary artery bypass surgery?, Saudi Med J, 29, 1429
Canbaz, 2008, The role of inflammation in atrial fibrillation following open heart surgery, J Int Med Res, 36, 1070, 10.1177/147323000803600526
Ucar, 2007, Predictive significance of plasma levels of interleukin-6 and high-sensitivity C-reactive protein in atrial fibrillation after coronary artery bypass surgery, Heart Surg Forum, 10, E131, 10.1532/HSF98.20061175
Hogue, 2006, C-reactive protein levels and atrial fibrillation after cardiac surgery in women, Ann Thorac Surg, 82, 97, 10.1016/j.athoracsur.2006.02.043
Cosgrave, 2005, Perioperative serum inflammatory response and the development of atrial fibrillation after coronary artery bypass surgery, Heart, 91, 1475, 10.1136/hrt.2004.054262
Lo, 2005, C-reactive protein is a risk indicator for atrial fibrillation after myocardial revascularization, Ann Thorac Surg, 79, 1530, 10.1016/j.athoracsur.2004.10.004
Mandal, 2005, Association of high intracellular, but not serum, heat shock protein 70 with postoperative atrial fibrillation, Ann Thorac Surg, 79, 865, 10.1016/j.athoracsur.2004.08.018
Mandal, 2004, Association of anti-heat shock protein 65 antibodies with development of postoperative atrial fibrillation, Circulation, 110, 2588, 10.1161/01.CIR.0000136825.96029.A5
Gungor, 2011, Serum resistin level: as a predictor of atrial fibrillation after coronary artery bypass graft surgery, Coron Artery Dis, 22, 484, 10.1097/MCA.0b013e32834b67bb
Buob, 2006, Discordant regulation of CRP and NT-proBNP plasma levels after electrical cardioversion of persistent atrial fibrillation, Pacing Clin Electrophysiol, 29, 559, 10.1111/j.1540-8159.2006.00401.x
Cosgrave, 2006, Inflammatory markers are not associated with outcomes following elective external cardioversion, Int J Cardiol, 110, 373, 10.1016/j.ijcard.2005.08.028
Malouf, 2005, High sensitivity C-reactive protein: a novel predictor for recurrence of atrial fibrillation after successful cardioversion, J Am Coll Cardiol, 46, 1284, 10.1016/j.jacc.2005.06.053
Korantzopoulos, 2005, Variation of inflammatory indexes after electrical cardioversion of persistent atrial fibrillation. Is there an association with early recurrence rates?, Int J Clin Pract, 59, 881, 10.1111/j.1368-5031.2005.00569.x
Wazni, 2005, C reactive protein concentration and recurrence of atrial fibrillation after electrical cardioversion, Heart, 91, 1303, 10.1136/hrt.2004.038661
Okumura, 2011, Impact of biomarkers of inflammation and extracellular matrix turnover on the outcome of atrial fibrillation ablation: importance of matrix metalloproteinase-2 as a predictor of atrial fibrillation recurrence, J Cardiovasc Electrophysiol, 22, 987, 10.1111/j.1540-8167.2011.02059.x
Lin, 2010, Prognostic implications of the high-sensitive C-reactive protein in the catheter ablation of atrial fibrillation, Am J Cardiol, 105, 495, 10.1016/j.amjcard.2009.10.019
Koyama, 2009, Comparison of characteristics and significance of immediate versus early versus no recurrence of atrial fibrillation after catheter ablation, Am J Cardiol, 103, 1249, 10.1016/j.amjcard.2009.01.010
Lellouche, 2009, Usefulness of C-reactive protein in predicting early and late recurrences after atrial fibrillation ablation, Europace, 11, 662, 10.1093/europace/eup077
Letsas, 2009, Pre-ablative predictors of atrial fibrillation recurrence following pulmonary vein isolation: the potential role of inflammation, Europace, 11, 158, 10.1093/europace/eun309
Rotter, 2006, Decline in C-reactive protein after successful ablation of long-lasting persistent atrial fibrillation, J Am Coll Cardiol, 47, 1231, 10.1016/j.jacc.2005.12.038
Moe, 1964, A computer model of atrial fibrillation, Am Heart J, 67, 200, 10.1016/0002-8703(64)90371-0
Allessie, 1985
Haissaguerre, 1998, Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins, N Engl J Med, 339, 659, 10.1056/NEJM199809033391003
Shiroshita-Takeshita, 2005, Atrial fibrillation: basic mechanisms, remodeling and triggers, J Interv Card Electrophysiol, 13, 181, 10.1007/s10840-005-2362-y
Kannel, 2009, Current perceptions of the epidemiology of atrial fibrillation, Cardiol Clin, 27, 13, 10.1016/j.ccl.2008.09.015
Kourliouros, 2009, Does inflammation influence atrial fibrillation recurrence following catheter ablation?, Europace, 11, 135, 10.1093/europace/eun386
Wu, 1992, Influence of long-chain acylcarnitines on voltage-dependent calcium current in adult ventricular myocytes, Am J Physiol, 263, H410
Acevedo, 2006, C-reactive protein and atrial fibrillation: “evidence for the presence of inflammation in the perpetuation of the arrhythmia”, Int J Cardiol, 108, 326, 10.1016/j.ijcard.2005.05.017
Ridker, 1997, Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men, N Engl J Med, 336, 973, 10.1056/NEJM199704033361401
de Ferranti, 2007, C-reactive protein: a nontraditional serum marker of cardiovascular risk, Cardiovasc Pathol, 16, 14, 10.1016/j.carpath.2006.04.006
Rader, 2000, Inflammatory markers of coronary risk, N Engl J Med, 343, 1179, 10.1056/NEJM200010193431609
Goudis, 2012, Extracellular matrix alterations in the atria: insights into the mechanisms and perpetuation of atrial fibrillation, Europace, 14, 623, 10.1093/europace/eur398
Gramley, 2010, Atrial fibrosis and atrial fibrillation: the role of the TGF-beta1 signaling pathway, Int J Cardiol, 143, 405, 10.1016/j.ijcard.2009.03.110
Xiao, 2010, TGF-beta1 expression and atrial myocardium fibrosis increase in atrial fibrillation secondary to rheumatic heart disease, Clin Cardiol, 33, 149, 10.1002/clc.20713
Verheule, 2004, Increased vulnerability to atrial fibrillation in transgenic mice with selective atrial fibrosis caused by overexpression of TGF-beta1, Circ Res, 94, 1458, 10.1161/01.RES.0000129579.59664.9d
Blobe, 2000, Role of transforming growth factor beta in human disease, N Engl J Med, 342, 1350, 10.1056/NEJM200005043421807
Anselmi, 2009, Postoperative inflammatory reaction and atrial fibrillation: simple correlation or causation?, Ann Thorac Surg, 88, 326, 10.1016/j.athoracsur.2009.01.031
Maesen, 2012, Post-operative atrial fibrillation: a maze of mechanisms, Europace, 14, 159, 10.1093/europace/eur208
Goldstein, 2005, New antiarrhythmic drugs for prevention of atrial fibrillation, Prog Cardiovasc Dis, 48, 193, 10.1016/j.pcad.2005.06.013
Liu, 2005, Anti-inflammatory therapies in atrial fibrillation, Int J Cardiol, 104, 359, 10.1016/j.ijcard.2005.05.074
Kuhn, 2013, Preoperative statin therapy in cardiac surgery: a meta-analysis of 90000 patients, Eur J Cardiothorac Surg
Fauchier, 2013, Statin therapy and atrial fibrillation: systematic review and updated meta-analysis of published randomized controlled trials, Curr Opin Cardiol, 28, 7, 10.1097/HCO.0b013e32835b0956
Yin, 2010, Effect of statins in preventing postoperative atrial fibrillation following cardiac surgery, Heart Lung Circ, 19, 579, 10.1016/j.hlc.2010.06.664
Loffredo, 2012, Upstream therapy with statin and recurrence of atrial fibrillation after electrical cardioversion. Review of the literature and meta-analysis, BMC Cardiovasc Disord, 12, 107, 10.1186/1471-2261-12-107
Zhou, 2013, Statin therapy is beneficial for the prevention of atrial fibrillation in patients with coronary artery disease: a meta-analysis, Eur J Pharmacol, 707, 104, 10.1016/j.ejphar.2013.03.012
Zhou, 2013, Statins therapy can reduce the risk of atrial fibrillation in patients with acute coronary syndrome: a meta-analysis, Int J Med Sci, 10, 198, 10.7150/ijms.5248